Comirnaty, who? It’s the same exact mRNA vaccine Pfizer has producing through the emergency use authorization, but now it’s being marketed under the new name. Comirnaty is administered in two doses, three weeks apart, just like Pfizer doses have been all along. The vaccine n...
IM injections Allergy medications, certain antibiotics and contraceptive hormones, other hormones such as testosterone, Botox, steroids, flu shots, Comirnaty (COVID-19 vaccine, mRNA) and other vaccines, B12 injections and certain antipsychotic drugs SC injections Insulin and other medications for diabet...
The researchers would no doubt argue they were erring on the side of caution, but their assessment of case 17 strains all boundaries of credulity. This case involved a 72 year-old woman who literally died within a few minutes of being injected with Comirnaty at a vaccination center. Yet th...
38, 39, 40, 41, 42 Another article found no evidence of oropharyngeal shedding of human Herpes viruses before or after vaccination with the Pfizer-BioNTech COVID-19 mRNA vaccine in Israel.43 The potential mechanism of human herpesvirus (HHV) reactivation is not known. Furthermore, given that ...
Global biopharmaceutical companies focus on Asia as the hub of their clinical trials to develop mRNA vaccines, and Korea has been chosen by none.BioNTech, which developed the Covid-19 vaccine, Comirnaty, said Monday that it would set up a clinical trial
One important statistic that needs to be mentioned is that both mRNA vaccines have been shown to prevent hospitalizations and deaths. This means that even in the rare case of a vaccinated individual developing COVID-19, the likelihood of them being hospitalized or dying is...
A recent publication by Klein and colleagues has reported an interim analysis from the surveillance data from the US Vaccine Safety Datalink database of 6.2 million people following 11.8 million doses of the mRNA COVID-19 vaccines, the BNT162b2 Pfizer-BioNTech vaccine (Comirnaty) or the Modern...
Only the Comirnaty (Pfizer/BioNTech) vaccine targets the Omicron JN.1 variant [28]. Two of the vaccines approved by the WHO, EMA or FDA were developed using mRNA, three using non-replicating viral vectors, five using protein subunit particles and one using an inactivated virus (Table 3)....